https://pharminent.com/strategic-news-watch/strategic-news-watch-july-10-2026/ 2026-07-10T16:37:41Z Pharminent en Strategic News Watch • July 10, 2026 2026-07-10T16:37:39Z Blog https://pharminent.com/aaic-2026-tau-targeted-alzheimers-treatments-heat-up-while-amyloid-therapies-persist/ 2026-07-10T20:43:52Z Pharminent en AAIC 2026: Tau-targeted Alzheimer's treatments heat up while amyloid therapies persist 2026-07-10T14:31:07Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-july-9-2026/ 2026-07-10T13:19:37Z Pharminent en Rare Disease & Gene Therapy Digest • July 9, 2026 2026-07-10T13:19:35Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-july-3-2026/ 2026-07-10T13:17:13Z Pharminent en Oncology Intelligence Digest • July 3, 2026 2026-07-10T13:17:11Z Blog https://pharminent.com/teva-and-polpharma-biologics-sign-global-deal-for-ocrelizumab-biosimilar-2/ 2026-07-10T20:41:53Z Pharminent en Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar 2026-07-10T09:31:18Z Blog https://pharminent.com/roche-scraps-two-ionis-partnered-huntingtons-drugs/ 2026-07-10T20:43:25Z Pharminent en Roche scraps two Ionis-partnered Huntington's drugs 2026-07-09T20:53:00Z Blog https://pharminent.com/astrazeneca-and-ionis-shares-fall-after-wainua-misses-primary-endpoint-in-attr-cardiomyopathy-trial/ 2026-07-09T20:05:09Z Pharminent en AstraZeneca and Ionis Shares Fall After Wainua Misses Primary Endpoint in ATTR Cardiomyopathy Trial 2026-07-09T20:05:05Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-july-9-2026/ 2026-07-09T15:48:52Z Pharminent en Strategic News Watch • July 9, 2026 2026-07-09T15:48:50Z Blog https://pharminent.com/keenova-eyes-xiaflex-as-first-drug-for-plantar-fibromatosis/ 2026-07-09T15:13:38Z Pharminent en Keenova eyes Xiaflex as first drug for plantar fibromatosis 2026-07-09T12:47:57Z Blog https://pharminent.com/astrazeneca-ionis-drug-fails-big-heart-disease-study-in-major-setback/ 2026-07-09T21:27:04Z Pharminent en AstraZeneca, Ionis drug fails big heart disease study in major setback 2026-07-09T11:54:00Z Blog https://pharminent.com/gsk-ends-dementia-alliance-with-alector-after-setbacks/ 2026-07-10T20:48:09Z Pharminent en GSK ends dementia alliance with Alector after setbacks 2026-07-09T11:25:10Z Blog https://pharminent.com/fda-freezes-crl-trove-as-radical-transparency-push-hits-speedbump/ 2026-07-09T17:21:29Z Pharminent en FDA freezes CRL trove as 'radical transparency' push hits speedbump 2026-07-09T10:42:43Z Blog https://pharminent.com/nice-aims-to-cut-funding-for-amgen-lung-cancer-drug-lumykras/ 2026-07-10T20:47:56Z Pharminent en NICE aims to cut funding for Amgen lung cancer drug Lumykras 2026-07-09T10:39:53Z Blog https://pharminent.com/uk-first-in-europe-to-clear-boehringers-ipf-drug-jascayd/ 2026-07-09T21:27:34Z Pharminent en UK first in Europe to clear Boehringer's IPF drug Jascayd 2026-07-09T08:44:31Z Blog https://pharminent.com/fda-warning-letter-hits-sanofis-genzyme-ireland-site/ 2026-07-08T20:33:20Z Pharminent en FDA Warning Letter Hits Sanofi's Genzyme Ireland Site 2026-07-08T20:33:04Z Blog https://pharminent.com/sino-biopharm-strikes-drug-licensing-deal-with-astrazeneca-deepens-partnership-with-gsk/ 2026-07-08T20:14:03Z Pharminent en Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens Partnership With GSK 2026-07-08T20:02:37Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-july-8-2026/ 2026-07-08T17:45:17Z Pharminent en Manufacturing Intelligence • Weekly Digest • July 8, 2026 2026-07-08T17:45:15Z Blog https://pharminent.com/tanabe-pens-deal-to-sell-plants-to-towa-in-post-buyout-pivot/ 2026-07-09T17:24:16Z Pharminent en Tanabe pens deal to sell plants to Towa in post-buyout pivot 2026-07-08T16:17:21Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-july-8-2026/ 2026-07-08T15:58:22Z Pharminent en Strategic News Watch • July 8, 2026 2026-07-08T15:58:20Z Blog https://pharminent.com/astrazeneca-gsk-intensify-china-ties-with-sino-biopharm-deals/ 2026-07-09T15:13:15Z Pharminent en AstraZeneca, GSK intensify China ties with Sino Biopharm deals 2026-07-08T15:58:00Z Blog https://pharminent.com/astrazeneca-bets-up-to-1-9b-in-respiratory-disease-collab-with-sino-biopharmaceutical/ 2026-07-10T20:47:39Z Pharminent en AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical 2026-07-08T12:01:41Z Blog